Author

Sejal Khanna

Indian Institute of Science Bangalore

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Mohit Kumar JollyiD· 2 shared Sarthak SahooiD· 2 shared Debashish PauliD· 1 shared Dimple NotaniiD· 1 shared Hemant Kumar· 1 shared Jyothi S. PrabhuiD· 1 shared Shoubhik ChakrabortyiD· 1 shared Sneha Ayalur Kumar· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

Mohit Kumar JollyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Nanomechanical Fingerprint of Centromeric Methylation Co-Localization in TNBC Chromosomal Instability

Tanya Agrawal, Shoubhik Chakraborty, Sejal Khanna, Sarthak Sahoo, Mohit Kumar Jolly, Sneha Ayalur Kumar, Debashish Paul, Suman Majumder, Snehasis Mukherjee, Tatini Rakshit

This study maps 5mC and H3K9me3 co-localization on individual chromosomes using AFM, revealing mechanical stiffness differences between cancer and non-tumorigenic cells.

bioRxiv · Oct 4, 2026 · PreprintBiophysics

Endocrine therapy-specific lineage and partial epithelial-mesenchymal reprogramming defines divergent resistant cell-states in ER+ breast cancer

Sarthak Sahoo, Sejal Khanna, Swayamshree Senapati, Hemant Kumar, Jyothi S. Prabhu, Dimple Notani, Sridhar S. Hannenhalli, Mohit Kumar Jolly

This study identifies drug-specific resistance mechanisms in ER+ breast cancer by analyzing multi-omic data, revealing distinct transcriptional and chromatin states associated with SERM, SERD, and ESR1 mutant resistance.

bioRxiv · May 13, 2026 · PreprintCancer Biology